Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Chernett Jorey is named as a reporting person in SEC Form 4 filings. OQRO lists 36 transactions filed with the SEC under this name, the latest on Nov 14, 2026, each linked to the official Form 4.
Disclosures on record
36
Companies involved
3
21 buys, median +52.0 pts vs S&P 500, beat it 16 of 21 times.
Average +53.7 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Mar 4, 2026 to Jul 15, 2026, measured from the first close after the filing. Past results, not a forecast.
28 purchases disclosed; 76% of the 21 measured at 90 days finished ahead of the index. $1,000 placed after each of the 27 purchases disclosed since 2025-11-14 would be worth $17K today ($27K put in); the same in the S&P 500 (SPY): $29K.
Rank 1 of the 82 insiders with at least 10 purchases measured at 90 days. The middle of that group is −5.5 pts (median, against the S&P 500).
NeuroneticsSTIM
22 disclosures · Mar 2026 – Nov 2026 · 16 bought · 6 sold
Nov 9, 2026Bought~$80Kdisclosed Nov 14
DetailsOfficial recordNov 13, 2026Sold~$2.52Mdisclosed Nov 14
DetailsEqual weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Nov 12, 2026Sold~$1.01Mdisclosed Nov 14
DetailsOfficial recordNov 6, 2026Sold~$599Kdisclosed Nov 14
DetailsOfficial recordNov 9, 2026Sold~$214Kdisclosed Nov 14
DetailsOfficial recordNov 11, 2026Sold~$140Kdisclosed Nov 14
DetailsOfficial recordOct 30, 2026Bought~$41Kdisclosed Nov 2
DetailsOfficial recordAug 14, 2026Bought~$44Kdisclosed Aug 17
DetailsOfficial recordAug 13, 2026Sold~$321disclosed Aug 17
DetailsOfficial recordJul 14, 2026Bought~$62Kdisclosed Jul 15
DetailsOfficial recordMay 19, 2026Bought~$117Kdisclosed May 20
DetailsOfficial recordMay 12, 2026Bought~$637Kdisclosed May 13
DetailsOfficial recordApr 20, 2026Bought~$158Kdisclosed Apr 22
DetailsOfficial recordApr 21, 2026Bought~$151Kdisclosed Apr 22
DetailsOfficial recordMar 27, 2026Bought~$675Kdisclosed Mar 30
DetailsOfficial recordMar 30, 2026Bought~$482K
DetailsOfficial recordMar 25, 2026Bought~$175Kdisclosed Mar 27
DetailsOfficial recordMar 26, 2026Bought~$36Kdisclosed Mar 27
DetailsOfficial recordMar 20, 2026Bought~$239Kdisclosed Mar 23
DetailsOfficial recordMar 18, 2026Bought~$820Kdisclosed Mar 20
DetailsOfficial recordMar 19, 2026Bought~$599Kdisclosed Mar 20
DetailsOfficial recordMar 17, 2026Bought~$616Kdisclosed Mar 18
DetailsOfficial recordExagenXGN
7 disclosures · Oct 2026 – Nov 2026 · 4 bought · 3 sold
Nov 12, 2026Sold~$509Kdisclosed Nov 14
DetailsOfficial recordNov 13, 2026Sold~$237Kdisclosed Nov 14
DetailsOfficial recordNov 11, 2026Bought~$373Kdisclosed Nov 12
DetailsOfficial recordNov 9, 2026Bought~$54Kdisclosed Nov 11
DetailsOfficial recordNov 10, 2026Bought~$37Kdisclosed Nov 11
DetailsOfficial recordNov 6, 2026Sold~$69Kdisclosed Nov 11
DetailsOfficial recordOct 19, 2026Bought~$104Kdisclosed Oct 20
DetailsOfficial recordStarling OncologySTLN
7 disclosures · Nov 2026 · 1 bought · 1 sold
Nov 11, 20261,391disclosed Nov 14
DetailsOfficial recordNov 9, 2026Bought~$176Kdisclosed Nov 10
DetailsOfficial recordNov 6, 2026Sold~$11.4Mdisclosed Nov 10
DetailsOfficial recordNov 9, 20267,500disclosed Nov 10
DetailsOfficial recordNov 6, 202610Kdisclosed Nov 10
DetailsOfficial recordNov 6, 20265,000disclosed Nov 10
DetailsOfficial recordNov 10, 20267,000
DetailsOfficial recordAs of the latest filing on , Chernett Jorey reported holding 7,858,091 shares of Starling Oncology (STLN), worth about $27.5M at the last close of $4 (Nov 13, 2026). Holdings are also on file at Exagen (XGN), Neuronetics (STIM), Airsculpt Technologies (AIRS); together they are worth about $54M. In the last 12 months, Chernett Jorey bought $5.68M in 21 open-market purchases and sold $16.7M in 10 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Starling Oncology STLN | 7,858,091 | 7.86M direct | $4 | $27.5M | Nov 9, 2026 |
| Exagen XGN | 2,529,436 | 2.53M direct | $4 | $10.4M | Nov 13, 2026 |
| Neuronetics STIM | 7,325,577 | 7.33M direct | $1 | $10.2M | Nov 13, 2026 |
| Airsculpt Technologies AIRS | 7,053,761 | 7.05M direct | $1 | $5.9M | Apr 17, 2026 |
Is this Chernett Jorey’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Chernett Jorey bought shares on the open market in 2026 across 3 companies. Sales in 1 of the 1 years since 2026.
Chernett Jorey reported 21 open-market purchases and 10 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $5.68M21×21 trades | $16.7M10×10 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 9, 2026, Chernett Jorey reported holding 7,858,091 shares of Starling Oncology (STLN). At the last close of $4 on Nov 13, 2026, that is about $27.5M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Chernett Jorey reported 10 open-market sales worth $16.7M and 21 open-market purchases worth $5.68M. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Chernett Jorey bought shares on the open market in 2026 across 3 companies. Sales in 1 of the 1 years since 2026.
In SEC filings since 2026: the latest open-market purchase is from 2026; the latest open-market sale is from 2026.
3 companies: Neuronetics (STIM, 2026), Exagen (XGN, 2026), Starling Oncology (STLN, 2026).
Chernett Jorey reported 16 open-market purchases and 6 sales here, 2026.
Chernett Jorey reported 4 open-market purchases and 3 sales here, 2026.
Chernett Jorey reported 1 open-market purchase and 1 sale here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
